Roxadustat, also known as FG‐4592, is an oral PHD inhibitor and is used for the treatment of anaemia in patients with chronic kidney disease (CKD).13, 14 We hypothesized whether FG‐4592 could alleviate radiation‐induced injuries as a HIF regulator. Here, PDC is linked to anemia (phenotype).